PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 53 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

29 January 2025

  1. (diff | hist) m b 07:22 Personal importation policy 2,232 ±0 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  2. (diff | hist) 05:04 Global access disparity 2,195 +218 AnalyticalAnnie (talk | contribs) split §Pricing from §Coverage [rollback]
  3. (diff | hist) 03:02 Third-party testing 5,087 +26 MelanocortinMil (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  4. (diff | hist) 02:32 Sangon Biotech 5,001 +192 EpitalonEoin (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]

28 January 2025

  1. (diff | hist) 20:38 GLP-1 receptor agonist 9,254 +1,083 MolarMassMaeve (talk | contribs) add the excipient list from the labelling [rollback]
  2. (diff | hist) 17:57 Triple agonist 3,147 +27 GMP_Gita (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  3. (diff | hist) m b 09:11 Tianjin Finder Chemical 5,817 +417 CategoryBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) N 09:00 Multi-dose vial 2,077 +2,077 SharpsSukhi (talk | contribs) start article; worked example to follow
  5. (diff | hist) m 07:07 Enteroendocrine L cell 4,619 +512 ColumnOvenCoy (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) m 05:03 Peptide synthesis 4,113 ±0 CustomsClarke (talk | contribs) ce, tighten prose [rollback]
  7. (diff | hist) 03:36 Janoshik Analytical 4,126 ±0 SurpassSunniva (talk | contribs) state the date range the submitted set covers [rollback]
  8. (diff | hist) 01:03 Prescribing information 3,458 +135 CostPerMgCory (talk | contribs) add the manufacturer assistance programme with its eligibility criterion [rollback]

27 January 2025

  1. (diff | hist) m 21:00 Test report forgery 3,874 +265 CouplingCillian (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  2. (diff | hist) m b 10:56 Orforglipron 3,337 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 06:11 CagriSema 2,989 +74 UnderfillUna (talk | contribs) add the molecular formula to the infobox [rollback]
  4. (diff | hist) 05:22 Cost per milligram 1,917 +33 TierTwoTansy (talk | contribs) add the prior-authorisation criterion as attributed to the payer document [rollback]
  5. (diff | hist) m b 04:06 SURMOUNT trial programme 3,270 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 02:23 Methionine oxidation 2,680 ±0 Ref_Desk_Ron (talk | contribs) expand §Chemistry and promoters [rollback]

26 January 2025

  1. (diff | hist) 18:44 Bacterial endotoxin test 4,398 +296 BiosimilarBoaz (talk | contribs) add the note on co-elution and what it hides [rollback]
  2. (diff | hist) m 15:22 Purity claim inflation 3,067 ±0 ExenatideEzra (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  3. (diff | hist) m 12:21 GLP-1 receptor 5,522 ±0 SPPS_Sorrel (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  4. (diff | hist) 09:18 Sterile water for injection 3,619 +390 RotationRosalind (talk | contribs) fix the arithmetic in the worked reconstitution example [rollback]
  5. (diff | hist) 08:27 List of GLP-1 receptor agonists 3,023 ±0 Retention_Time_Rae (talk | contribs) renumber the timeline after inserting the 2023 entry [rollback]
  6. (diff | hist) 06:49 Melanotan II 2,703 ±0 API_Aurora (talk | contribs) fix a dangling clause [rollback]
  7. (diff | hist) 06:00 Liraglutide 4,295 ±0 EscalationEira (talk | contribs) split overlong sentence [rollback]
  8. (diff | hist) 05:32 Patent expiry and biosimilars 2,578 ±0 ShortageShona (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  9. (diff | hist) 04:47 Retatrutide 5,700 +1,103 LiraLotte (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  10. (diff | hist) 02:43 Reconstitution calculator 4,456 +151 NauseaNoor (talk | contribs) add keyboard operation to the control description [rollback]

25 January 2025

  1. (diff | hist) 23:37 Albumin binding half-life extension 4,511 +110 BUD_Bertram (talk | contribs) expand §Physical basis [rollback]
  2. (diff | hist) 22:23 Beyond-use date 9,787 +900 eGFR_Esme (talk | contribs) add the dead-space volume to the worked example [rollback]
  3. (diff | hist) m 20:37 Aspiration risk under anaesthesia 3,608 +30 SiteReactionSuz (talk | contribs) flag the section as needing a source for two remaining figures [rollback]
  4. (diff | hist) 19:55 USP General Chapter 85 3,416 +748 DrTitration (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  5. (diff | hist) 14:14 Grey market 2,576 ±0 FmocFrancis (talk | contribs) expand §Relevance to this wiki [rollback]
  6. (diff | hist) 10:28 STEP trial programme 4,357 +293 ToleranceTove (talk | contribs) correct the baseline mean — transposed digits [rollback]
  7. (diff | hist) 10:14 Talk:Bachem Holding (Suzhou) 1,455 +156 RfC_Rasmus (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  8. (diff | hist) m 09:56 Dulaglutide 3,990 +123 BiliaryBea (talk | contribs) add the structural figure and caption it properly [rollback]
  9. (diff | hist) 09:38 Analytical method validation 4,021 ±0 ResolutionRoo (talk | contribs) add the repeatability figure with the number of injections [rollback]
  10. (diff | hist) m 07:51 Custom peptide synthesis 3,249 +35 FmocFrancis (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  11. (diff | hist) 06:20 Contract development and manufacturing organisation 2,875 ±0 PrepHPLC_Pia (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  12. (diff | hist) 01:01 Limit of detection 3,971 +293 AAA_Analyst (talk | contribs) expand §How it is determined [rollback]
  13. (diff | hist) m 00:36 VendorInvestigate 3,585 +102 MicrodoseMagnus (talk | contribs) add category for certificates of analysis [rollback]

24 January 2025

  1. (diff | hist) m b 23:51 Amino acid analysis 2,621 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  2. (diff | hist) 22:32 Shanghai Wibson Biotechnology 2,202 +441 Chromatokid (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  3. (diff | hist) m 22:19 Glossary of peptide terminology 3,581 ±0 GlossaryGleb (talk | contribs) add the year of first description to each glossary term where known [rollback]
  4. (diff | hist) 21:19 Glucagon-like peptide-1 10,017 ±0 BetaCellBoyd (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  5. (diff | hist) m 18:24 Cold chain 17,977 +307 SemaglutideSasha (talk | contribs) fix a dangling clause [rollback]
  6. (diff | hist) m b 14:19 LEADER trial 3,277 +99 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) 13:36 Repackaging 3,597 +39 CouplingCillian (talk | contribs) state the difference between a validated shipper and an insulated box [rollback]
  8. (diff | hist) m b 13:31 HOMA-IR 3,208 +30 CiteBot (talk | contribs) bot: sort category members [rollback]
  9. (diff | hist) 12:28 Chinese Peptide Company 9,152 +412 Compounding_Cate (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  10. (diff | hist) 11:46 Peptide harm reduction 2,785 ±0 Compounding_Cate (talk | contribs) state that the pricing data is self-reported where it is [rollback]
  11. (diff | hist) 05:21 Preparative HPLC purification 3,866 +23 CounterfeitCato (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]

23 January 2025

  1. (diff | hist) 20:31 Lixisenatide 2,936 +634 StyleSheetSybil (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  2. (diff | hist) 17:42 Proglucagon 4,998 +742 ThymosinTamsin (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  3. (diff | hist) 17:15 Lyophilisation 16,876 +1,442 SurmountSurma (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  4. (diff | hist) 15:16 Dose escalation schedule 3,510 +640 PrepHPLC_Pia (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  5. (diff | hist) m 14:17 SURPASS trial programme 3,958 +184 SurmountSurma (talk | contribs) British spelling per PP:MOS [rollback]
  6. (diff | hist) 08:41 Talk:Bachem Holding (Suzhou) 959 +194 Chromatokid (talk | contribs) /* Purity without a reference standard */ reply
  7. (diff | hist) 05:03 Blind sampling 4,974 +153 BatchNumberBede (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  8. (diff | hist) m 03:49 Insulin syringe unit conversion 3,205 +119 BalanceBirdie (talk | contribs) expand §Scale comparison [rollback]
  9. (diff | hist) m b 00:58 Sarcopenia 2,738 +419 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]

22 January 2025

  1. (diff | hist) 21:59 ChinaPeptides 6,159 +642 MelanocortinMil (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) m 17:48 Peptide stability table 1,939 +33 CrossRefCleve (talk | contribs) add the worked example that matches the default inputs [rollback]
  3. (diff | hist) 13:14 Talk:Bachem Holding (Suzhou) 748 +223 AnalyticalAnnie (talk | contribs) /* Purity without a reference standard */ reply
  4. (diff | hist) 09:36 Talk:Bachem Holding (Suzhou) 537 +245 AAA_Analyst (talk | contribs) /* Purity without a reference standard */ new section
  5. (diff | hist) 09:01 Active pharmaceutical ingredient 2,832 ±0 LabRangeLindy (talk | contribs) state that research-use-only labelling is a commercial category, not an approval [rollback]
  6. (diff | hist) m 08:45 Electrospray ionisation 3,226 +111 PeakShapePol (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) 08:30 Certificate of analysis 6,396 ±0 GlossaryGleb (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  8. (diff | hist) m 00:47 Vial filling and stoppering 3,355 +582 StopperingSteff (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]

21 January 2025

  1. (diff | hist) 17:12 Drug master file 2,228 ±0 SafetySignalSid (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  2. (diff | hist) m 16:46 Crude peptide 3,318 ±0 SecretagogueSol (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  3. (diff | hist) 15:25 Semaglutide 7,098 +365 ComparisonCato (talk | contribs) add the structural figure and caption it properly [rollback]
  4. (diff | hist) 14:52 Deamidation 3,497 ±0 A1c_Alder (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  5. (diff | hist) 09:35 Subcutaneous injection 4,039 +194 SelectTrialSam (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  6. (diff | hist) m 09:29 USP General Chapter 71 2,254 ±0 StyleSheetSybil (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  7. (diff | hist) 06:26 Tirzepatide 5,389 ±0 TimelineTiernan (talk | contribs) add CAS number, sourced [rollback]
  8. (diff | hist) m 05:32 Timeline of incretin therapeutics 3,151 +19 INN_Ingrid (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  9. (diff | hist) 04:24 Peptide 4,059 ±0 AmylinAmos (talk | contribs) add short description [rollback]
  10. (diff | hist) 04:20 Solid-phase peptide synthesis 4,279 ±0 PrepHPLC_Pia (talk | contribs) add category for logistics [rollback]

20 January 2025

  1. (diff | hist) 20:58 Trial data comparison 2,049 +503 DiffWatchDov (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  2. (diff | hist) 17:13 Peptide supply chain 4,176 +33 Chromatokid (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  3. (diff | hist) 16:41 Injection site rotation 3,555 +586 NauseaNoor (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  4. (diff | hist) m 15:33 Lot traceability 4,002 +220 OpenLabelOtto (talk | contribs) add the turnaround time the service publishes [rollback]
  5. (diff | hist) 15:01 Hypoglycaemia 3,477 ±0 SarcopeniaSefa (talk | contribs) state whether the figure is from a trial or from post-marketing reporting [rollback]
  6. (diff | hist) 14:48 Talk:Bachem Holding (Suzhou) 1,244 +207 BalanceBirdie (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  7. (diff | hist) 14:12 Research use only 6,662 +21 DMF_Dermot (talk | contribs) split overlong sentence [rollback]
  8. (diff | hist) 07:04 WuXi TIDES 8,547 ±0 VerifyVesna (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  9. (diff | hist) 04:52 Body composition assessment 3,353 +124 MetricMabel (talk | contribs) state the assay the reference interval was established on [rollback]
  10. (diff | hist) 02:44 Chain of custody 3,802 ±0 MarginNoteMars (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  11. (diff | hist) 00:53 FLOW trial 3,097 +496 PioneerPerdita (talk | contribs) state that the trial has reported but is not yet peer-reviewed [rollback]

19 January 2025

  1. (diff | hist) 17:51 Area percent purity 5,999 +685 PBM_Perrin (talk | contribs) add the detection wavelength [rollback]
  2. (diff | hist) 16:40 Hunan Aslsen Technology 6,292 +280 CouplingCillian (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  3. (diff | hist) m b 15:46 Insulin secretion 4,555 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) m 13:31 Customs seizure 2,395 +31 Compounding_Cate (talk | contribs) add the effective date to the regulatory table [rollback]
  5. (diff | hist) 11:19 Number needed to treat 3,241 +34 DataTableDunja (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  6. (diff | hist) m 07:12 High-performance liquid chromatography 5,364 +646 DulaglutideDug (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  7. (diff | hist) m b 02:45 Underfilling 2,488 +105 CategoryBot (talk | contribs) bot: normalise citation format [rollback]

18 January 2025

  1. (diff | hist) 22:49 Fmoc chemistry 3,718 ±0 NPOV_Nadia (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  2. (diff | hist) 22:05 Survodutide 3,973 +648 Chromatokid (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 17:29 MOTS-c 2,663 +54 BPC_Bramwell (talk | contribs) fix a dangling clause [rollback]